The Clinical Outcomes of Coronary Stenting and Coronary Artery Bypass Grafting in ESRD Patients with Ischemic Heart Disease.
- Author:
Joon Seung YI
1
;
Jai Weon CHANG
;
Mee Sook LEE
;
Sang Pil CHANG
;
Seong Wook PARK
;
Cheol Whan LEE
;
Hyun SONG
;
Jung Sik PARK
Author Information
1. Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Coronary stenting;
Coronary artery bypass grafting;
End stage renal disease patient
- MeSH:
Case-Control Studies;
Coronary Artery Bypass*;
Coronary Vessels*;
Follow-Up Studies;
Heart;
Humans;
Kidney Failure, Chronic;
Mortality;
Myocardial Ischemia*;
Retrospective Studies;
Stents*;
Transplants;
Ventricular Function, Left
- From:Korean Journal of Nephrology
2001;20(2):250-257
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The purpose of this study was firstly, to evaluate the efficacy of coronary stenting in ESRD patients compared with non uremic patients and secondly, to compare the perioperative mortality of coronary artery bypass grafting(CABG) in ESRD patients with that in non-uremic patients exhibiting a similar degree of left ventricular function. We examined the clinical restenosis of coronary stenting and 30 day mortality rate after CABG in this retrospective, case-controlled study. The case histories of twenty-five ESRD patients with ischemic heart disease(IHD) and twenty-five non-uremic IHD patients matched for age, sex, ejection fraction and number of implanted stents, who had undergone first, elective, primarily successful coronary stenting were reviewed. The case of histories of another sixteen ESRD patients with IHD and sixteen non-uremic IHD patients matched for age, sex, ejection fraction and number of grafted vessels, who had undergone first elective CABG were also reviewed. Clinical restenosis developed in nine of the twenty-five ESRD patients and in eight of the twenty-five non-uremic patients after coronary stenting within follow up periods of 16.9+/-14.5 months and 17.6+/-14.6 months, respectively. There was no significant difference in the cumulative clinical restenosis free curves between the two groups(p=0.79). Three out of sixteen for the ESRD patients and one out of sixteen for the non-uremic patients died in 30 days after CABG, follow up periods being 11.3+/-9.6 months and 11.1+/-8.9 months, respectively. The perioperative mortality did not differ between the two groups(p=0.28). We conclude that coronary stenting in ESRD patients is as effective as in non-uremic patients regarding initial coronary revascularization and perioperative mortality rate of CABG in ESRD patients is not significantly higher compared with non-uremic patients when Left ventricular function is matched.
